Transmission-blocking strategies: the roadmap from laboratory bench to the community

[1]  Katya Galactionova,et al.  Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models , 2016, The Lancet.

[2]  Andrea Crisanti,et al.  A CRISPR-Cas9 Gene Drive System Targeting Female Reproduction in the Malaria Mosquito vector Anopheles gambiae , 2015, Nature Biotechnology.

[3]  Ethan Bier,et al.  Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi , 2015, Proceedings of the National Academy of Sciences.

[4]  S. C. T. P. Rts.  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial , 2015, The Lancet.

[5]  M. Rowland,et al.  Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan , 2015, Malaria Journal.

[6]  Peter G. Kremsner,et al.  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. , 2015 .

[7]  D. Nikolaeva,et al.  Toward the development of effective transmission-blocking vaccines for malaria , 2015, Expert review of vaccines.

[8]  Leslie B Vosshall,et al.  Genome engineering with CRISPR-Cas9 in the mosquito Aedes aegypti. , 2015, Cell reports.

[9]  D. Leboulleux,et al.  Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine. , 2015, Vaccine.

[10]  R. Sinden,et al.  Imaging-Based High-Throughput Screening Assay To Identify New Molecules with Transmission-Blocking Potential against Plasmodium falciparum Female Gamete Formation , 2015, Antimicrobial Agents and Chemotherapy.

[11]  P. Garner,et al.  Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission , 2015, The Cochrane database of systematic reviews.

[12]  R. Sinden,et al.  Experimental study of the relationship between Plasmodium gametocyte density and infection success in mosquitoes; implications for the evaluation of malaria transmission-reducing interventions. , 2015, Experimental parasitology.

[13]  Abdullah S. Ali,et al.  Loop-mediated isothermal amplification (LAMP) for point-of-care detection of asymptomatic low-density malaria parasite carriers in Zanzibar , 2015, Malaria Journal.

[14]  Mercedes Pascual,et al.  Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria , 2015, Proceedings of the National Academy of Sciences.

[15]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[16]  Emily P. Wen,et al.  Vaccine development and manufacturing , 2015 .

[17]  L. Okell,et al.  Asymptomatic malaria infections: detectability, transmissibility and public health relevance , 2014, Nature Reviews Microbiology.

[18]  S. Griffing,et al.  Malaria Control and Elimination, Venezuela, 1800s–1970s , 2014, Emerging infectious diseases.

[19]  H. Ranson,et al.  Increased Pyrethroid Resistance in Malaria Vectors and Decreased Bed Net Effectiveness, Burkina Faso , 2014, Emerging infectious diseases.

[20]  D. Kaslow,et al.  Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward. , 2014, Vaccine.

[21]  A. Rosanas-Urgell,et al.  Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria , 2014, Malaria Journal.

[22]  D. Kwiatkowski,et al.  Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.

[23]  J. Powell,et al.  Genetic shifting: a novel approach for controlling vector-borne diseases. , 2014, Trends in parasitology.

[24]  T. Bousema,et al.  A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages. , 2014, Vaccine.

[25]  F. Agusto,et al.  Impact of mating behaviour on the success of malaria control through a single inundative release of transgenic mosquitoes. , 2014, Journal of theoretical biology.

[26]  A. Ichinose,et al.  Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model. , 2014, Vaccine.

[27]  B. Striepen,et al.  Cell division in apicomplexan parasites , 2014, Nature Reviews Microbiology.

[28]  T. Bousema,et al.  Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. , 2014, The Lancet. Infectious diseases.

[29]  R. Kumar,et al.  Potent Malaria Transmission-Blocking Antibody Responses Elicited by Plasmodium falciparum Pfs25 Expressed in Escherichia coli after Successful Protein Refolding , 2014, Infection and Immunity.

[30]  A. Pandey,et al.  Multiple pathways for Plasmodium ookinete invasion of the mosquito midgut , 2014, Proceedings of the National Academy of Sciences.

[31]  L. Alphey.  Genetic control of mosquitoes. , 2014, Annual review of entomology.

[32]  David L. Smith,et al.  Modeling Within-Host Effects of Drugs on Plasmodium falciparum Transmission and Prospects for Malaria Elimination , 2014, PLoS Comput. Biol..

[33]  David L. Smith,et al.  Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics. , 2014, Advances in parasitology.

[34]  Developing inexpensive malaria vaccines from plants and algae , 2014, Applied Microbiology and Biotechnology.

[35]  Bernhard P. Konrad,et al.  Assessing the optimal virulence of malaria‐targeting mosquito pathogens: a mathematical study of engineered Metarhizium anisopliae , 2014, Malaria Journal.

[36]  A. Finnefrock,et al.  Antibodies to a Single, Conserved Epitope in Anopheles APN1 Inhibit Universal Transmission of Plasmodium falciparum and Plasmodium vivax Malaria , 2013, Infection and Immunity.

[37]  R. Sauerwein,et al.  A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice , 2013, PloS one.

[38]  V. Avery,et al.  Identification of inhibitors of Plasmodium falciparum gametocyte development , 2013, Malaria Journal.

[39]  C. Whitty,et al.  Cost-Effectiveness Analysis of Introducing RDTs for Malaria Diagnosis as Compared to Microscopy and Presumptive Diagnosis in Central and Peripheral Public Health Facilities in Ghana , 2013, The American journal of tropical medicine and hygiene.

[40]  T. Richie,et al.  The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review , 2013, Current opinion in infectious diseases.

[41]  Peter Siba,et al.  Strategies for Detection of Plasmodium species Gametocytes , 2013, PloS one.

[42]  Mario Roederer,et al.  Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine , 2013, Science.

[43]  N. Sardesai,et al.  Inducing Humoral and Cellular Responses to Multiple Sporozoite and Liver-Stage Malaria Antigens Using Exogenous Plasmid DNA , 2013, Infection and Immunity.

[44]  S. Krudsood,et al.  Definition of hyperparasitemia in severe falciparum malaria should be updated. , 2013, Asian Pacific journal of tropical biomedicine.

[45]  P. Gething,et al.  Transmission-blocking interventions eliminate malaria from laboratory populations , 2013, Nature Communications.

[46]  I. Kleinschmidt,et al.  High level of resistance in the mosquito Anopheles gambiae to pyrethroid insecticides and reduced susceptibility to bendiocarb in north-western Tanzania , 2013, Malaria Journal.

[47]  Kim Hendrickx,et al.  Winged Promises: Exploring the Discourse on Transgenic Mosquitoes in Brazil , 2013 .

[48]  Martin Walker,et al.  Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection , 2013, eLife.

[49]  David L. Smith,et al.  Malaria's Missing Number: Calculating the Human Component of R0 by a Within-Host Mechanistic Model of Plasmodium falciparum Infection and Transmission , 2013, PLoS Comput. Biol..

[50]  J. Perin,et al.  Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar , 2013, PloS one.

[51]  Sibao Wang,et al.  Genetic approaches to interfere with malaria transmission by vector mosquitoes. , 2013, Trends in biotechnology.

[52]  T. Bousema,et al.  Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions? , 2013, Trends in parasitology.

[53]  X. Su,et al.  Malaria biology and disease pathogenesis: insights for new treatments , 2013, Nature Medicine.

[54]  C. Kocken,et al.  Ex vivo culture of Plasmodium vivax and Plasmodium cynomolgi and in vitro culture of Plasmodium knowlesi blood stages. , 2013, Methods in molecular biology.

[55]  F. Simard,et al.  Multiple insecticide resistance mechanisms in Anopheles gambiae s.l. populations from Cameroon, Central Africa , 2013, Parasites & Vectors.

[56]  Y. Michalakis,et al.  Studying fitness cost of Plasmodium falciparum infection in malaria vectors: validation of an appropriate negative control , 2013, Malaria Journal.

[57]  X. Su,et al.  Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. , 2012, The Lancet. Infectious diseases.

[58]  J. Farrar,et al.  In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam , 2012, Malaria Journal.

[59]  J. Lelièvre,et al.  Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence “transmission blocking” assay , 2012, Malaria Journal.

[60]  P. Eckhoff,et al.  P. falciparum Infection Durations and Infectiousness Are Shaped by Antigenic Variation and Innate and Adaptive Host Immunity in a Mathematical Model , 2012, PloS one.

[61]  K. Deitsch,et al.  Antigenic variation and the generation of diversity in malaria parasites. , 2012, Current opinion in microbiology.

[62]  A. Ghosh,et al.  Fighting malaria with engineered symbiotic bacteria from vector mosquitoes , 2012, Proceedings of the National Academy of Sciences.

[63]  David L. Smith,et al.  Superinfection and the evolution of resistance to antimalarial drugs , 2012, Proceedings of the Royal Society B: Biological Sciences.

[64]  F. Nosten,et al.  Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.

[65]  Richard J. Maude,et al.  Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin Resistance , 2012, PloS one.

[66]  G. McFadden,et al.  Malaria parasite colonisation of the mosquito midgut--placing the Plasmodium ookinete centre stage. , 2012, International journal for parasitology.

[67]  David L. Smith,et al.  Malaria resurgence: a systematic review and assessment of its causes , 2012, Malaria Journal.

[68]  J. Lelièvre,et al.  Activity of Clinically Relevant Antimalarial Drugs on Plasmodium falciparum Mature Gametocytes in an ATP Bioluminescence “Transmission Blocking” Assay , 2012, Malaria Journal.

[69]  D. Leroy,et al.  Comparison and Optimization of Different Methods for the In Vitro Production of Plasmodium falciparum Gametocytes , 2012, Journal of parasitology research.

[70]  Nancy Fullman,et al.  Global malaria mortality between 1980 and 2010: a systematic analysis , 2012, The Lancet.

[71]  E. Winzeler,et al.  The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites , 2012, PLoS medicine.

[72]  J. Bryk,et al.  Scientific Standards and the Regulation of Genetically Modified Insects , 2012, PLoS neglected tropical diseases.

[73]  Thomas Smith,et al.  Reproduction numbers in malaria and their implications. , 2012, Trends in parasitology.

[74]  Didier Leroy,et al.  Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes? , 2012, Malaria Journal.

[75]  D. Fidock,et al.  Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum , 2011, Current opinion in infectious diseases.

[76]  C. Rogier,et al.  Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. , 2011, The Lancet. Infectious diseases.

[77]  T. Spicer,et al.  A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. , 2011, Molecular and biochemical parasitology.

[78]  L. Moreira,et al.  Can Wolbachia be used to control malaria? , 2011, Memorias do Instituto Oswaldo Cruz.

[79]  K. Williamson,et al.  A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. , 2011, Molecular and biochemical parasitology.

[80]  T. Jokiranta,et al.  Review of cases with the emerging fifth human malaria parasite, Plasmodium knowlesi. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  K. Williamson,et al.  A High-Throughput Screen Targeting Malaria Transmission Stages Opens New Avenues for Drug Development , 2011, The Journal of infectious diseases.

[82]  Thomas A. Smith,et al.  Uses of mosquito-stage transmission-blocking vaccines against Plasmodium falciparum. , 2011, Trends in parasitology.

[83]  Teun Bousema,et al.  Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.

[84]  Andrea Crisanti,et al.  A synthetic homing endonuclease-based gene drive system in the human malaria mosquito , 2011, Nature.

[85]  Angray S. Kang,et al.  Development of Transgenic Fungi That Kill Human Malaria Parasites in Mosquitoes , 2011, Science.

[86]  Nicolas Moiroux,et al.  Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? , 2011, Trends in parasitology.

[87]  Thomas Smith,et al.  A Research Agenda for Malaria Eradication: Modeling , 2011, PLoS medicine.

[88]  Pedro L. Alonso,et al.  Some Lessons for the Future from the Global Malaria Eradication Programme (1955–1969) , 2011, PLoS medicine.

[89]  J. Baird,et al.  Consideration of ethics in primaquine therapy against malaria transmission. , 2011, Trends in parasitology.

[90]  A. Llanos-Cuentas,et al.  Optimized in vitro production of Plasmodium vivax ookinetes. , 2010, The American journal of tropical medicine and hygiene.

[91]  J. Vinetz,et al.  In vitro generation of Plasmodium falciparum ookinetes. , 2010, The American journal of tropical medicine and hygiene.

[92]  Andrew J Tatem,et al.  Ranking of elimination feasibility between malaria-endemic countries , 2010, The Lancet.

[93]  R. Sinden,et al.  Population biology of malaria within the mosquito: density-dependent processes and potential implications for transmission-blocking interventions , 2010, Malaria Journal.

[94]  M. Pascual,et al.  Transmission Intensity and Drug Resistance in Malaria Population Dynamics: Implications for Climate Change , 2010, PloS one.

[95]  D. Baker,et al.  Malaria gametocytogenesis , 2010, Molecular and biochemical parasitology.

[96]  Wes Hinsley,et al.  Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies , 2010, PLoS medicine.

[97]  Caroline W. Kabaria,et al.  The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009 , 2010, PLoS neglected tropical diseases.

[98]  A. Ghosh,et al.  An improved method for the in vitro differentiation of Plasmodium falciparum gametocytes into ookinetes , 2010, Malaria Journal.

[99]  S. Krudsood,et al.  Appropriate time for primaquine treatment to reduce Plasmodium falciparum transmission in hypoendemic areas. , 2010, The Korean journal of parasitology.

[100]  M. Fay,et al.  The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species. , 2010, Vaccine.

[101]  Teun Bousema,et al.  Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs , 2010 .

[102]  James R. Brown,et al.  Thousands of chemical starting points for antimalarial lead identification , 2010, Nature.

[103]  G. Dimopoulos,et al.  Mosquito immune defenses against Plasmodium infection. , 2010, Developmental and comparative immunology.

[104]  D. Larsen,et al.  Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas , 2010, International journal of epidemiology.

[105]  J. Baird,et al.  Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. , 2010, Trends in parasitology.

[106]  A. Kuehn,et al.  The Coming-Out of Malaria Gametocytes , 2010, Journal of biomedicine & biotechnology.

[107]  F. Ou,et al.  Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine , 2010, Malaria Journal.

[108]  V. Nussenzweig,et al.  A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates , 2009, Proceedings of the National Academy of Sciences.

[109]  C. Bourgouin,et al.  Density-dependent impact of the human malaria parasite Plasmodium falciparum gametocyte sex ratio on mosquito infection rates , 2009, Proceedings of the Royal Society B: Biological Sciences.

[110]  Richard J Maude,et al.  The role of simple mathematical models in malaria elimination strategy design , 2009, Malaria Journal.

[111]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[112]  David L. Smith,et al.  Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations , 2009, Malaria Journal.

[113]  J. Ramirez,et al.  Challenges and approaches for mosquito targeted malaria control. , 2009, Current molecular medicine.

[114]  D. Hegedus,et al.  New insights into peritrophic matrix synthesis, architecture, and function. , 2009, Annual review of entomology.

[115]  Louise A Kelly-Hope,et al.  The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa , 2009, Malaria Journal.

[116]  A. Mills,et al.  Malaria eradication: the economic, financial and institutional challenge , 2008, Malaria Journal.

[117]  K. Stepniewska,et al.  Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria. , 2008, The American journal of tropical medicine and hygiene.

[118]  Jason L. Rasgon,et al.  Viral Paratransgenesis in the Malaria Vector Anopheles gambiae , 2008, PLoS pathogens.

[119]  M. Fay,et al.  Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51 , 2008, PloS one.

[120]  A. Tatem,et al.  The Limits and Intensity of Plasmodium falciparum Transmission : Implications for Malaria Control and Elimination Worldwide , 2007 .

[121]  M. Coosemans,et al.  Distribution of Anopheles in Vietnam, with particular attention to malaria vectors of the Anopheles minimus complex , 2008, Malaria Journal.

[122]  Hervé C Bossin,et al.  Transgenic mosquitoes and the fight against malaria: managing technology push in a turbulent GMO world. , 2007, The American journal of tropical medicine and hygiene.

[123]  U. d’Alessandro,et al.  Intensity of malaria transmission and the spread of Plasmodium falciparum resistant malaria: a review of epidemiologic field evidence. , 2007, The American journal of tropical medicine and hygiene.

[124]  H. Mwambi,et al.  Estimating Dispersal and Survival of Anopheles gambiae and Anopheles funestus Along the Kenyan Coast by Using Mark–Release–Recapture Methods , 2007, Journal of medical entomology.

[125]  G. Pradel,et al.  Proteins of the malaria parasite sexual stages: expression, function and potential for transmission blocking strategies , 2007, Parasitology.

[126]  S. Sharp,et al.  Improved synchronous production of Plasmodium falciparum gametocytes in vitro. , 2007, Molecular and biochemical parasitology.

[127]  Ajay K. Saxena,et al.  Plasmodium P25 and P28 Surface Proteins: Potential Transmission-Blocking Vaccines , 2007, Eukaryotic Cell.

[128]  K. Vernick,et al.  Efficiency of salivary gland invasion by malaria sporozoites is controlled by rapid sporozoite destruction in the mosquito haemocoel. , 2007, International journal for parasitology.

[129]  David Lampe,et al.  Using bacteria to express and display anti-Plasmodium molecules in the mosquito midgut. , 2007, International journal for parasitology.

[130]  Steven W Lindsay,et al.  High spatial resolution mapping of malaria transmission risk in the Gambia, west Africa, using LANDSAT TM satellite imagery. , 2007, The American journal of tropical medicine and hygiene.

[131]  R. Sauerwein,et al.  Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. , 2007, The American journal of tropical medicine and hygiene.

[132]  David L Smith,et al.  Revisiting the Basic Reproductive Number for Malaria and Its Implications for Malaria Control , 2007, PLoS biology.

[133]  J. Shiver,et al.  Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex , 2006, Proceedings of the National Academy of Sciences.

[134]  Ana Rodriguez,et al.  The silent path to thousands of merozoites: the Plasmodium liver stage , 2006, Nature Reviews Microbiology.

[135]  I. Hastings.  Gametocytocidal activity in antimalarial drugs speeds the spread of drug resistance , 2006, Tropical medicine & international health : TM & IH.

[136]  Gerry Killeen,et al.  Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum. , 2006, The American journal of tropical medicine and hygiene.

[137]  C. Drakeley,et al.  Transmission‐reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers , 2006, Parasite immunology.

[138]  S. Shorte,et al.  Quantitative imaging of Plasmodium transmission from mosquito to mammal , 2006, Nature Medicine.

[139]  L. Ranford-Cartwright,et al.  Spreading the seeds of million-murdering death: metamorphoses of malaria in the mosquito. , 2005, Trends in parasitology.

[140]  J. Dushoff,et al.  The entomological inoculation rate and Plasmodium falciparum infection in African children , 2005, Nature.

[141]  Darcy L. Medica,et al.  Quantitative Dynamics of Plasmodium yoelii Sporozoite Transmission by Infected Anopheline Mosquitoes , 2005, Infection and Immunity.

[142]  John R Yates,et al.  A Comprehensive Survey of the Plasmodium Life Cycle by Genomic, Transcriptomic, and Proteomic Analyses , 2005, Science.

[143]  G. Wunderlich,et al.  Antigenic Diversity and Immune Evasion by Malaria Parasites , 2004, Clinical Diagnostic Laboratory Immunology.

[144]  Petra Schneider,et al.  Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. , 2004, Molecular and biochemical parasitology.

[145]  J. Sattabongkot,et al.  Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy. , 2004, Vaccine.

[146]  M. Jacobs-Lorena,et al.  Mosquito midgut barriers to malaria parasite development. , 2004, Insect biochemistry and molecular biology.

[147]  Mathieu Nacher,et al.  Comparison of Artesunate and Chloroquine Activities against Plasmodium vivax Gametocytes , 2004, Antimicrobial Agents and Chemotherapy.

[148]  David L Smith,et al.  Statics and dynamics of malaria infection in Anopheles mosquitoes , 2004, Malaria Journal.

[149]  Nicholas J. White,et al.  Activities of Artesunate and Primaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria , 2004, Antimicrobial Agents and Chemotherapy.

[150]  H. Hurd.  Manipulation of medically important insect vectors by their parasites. , 2003, Annual review of entomology.

[151]  L. Zou,et al.  Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials. , 2003, Vaccine.

[152]  J. Meunier,et al.  Estimation of malaria transmission from humans to mosquitoes in two neighbouring villages in south Cameroon: evaluation and comparison of several indices. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[153]  David L. Tabb,et al.  A proteomic view of the Plasmodium falciparum life cycle , 2002, Nature.

[154]  Y. Han,et al.  Implications of Time Bomb model of ookinete invasion of midgut cells. , 2002, Insect biochemistry and molecular biology.

[155]  Salvatore Musumeci,et al.  The immune response to Plasmodium falciparum malaria. , 2002, The Lancet. Infectious diseases.

[156]  A. M. Ahmed,et al.  The costs of mounting an immune response are reflected in the reproductive fitness of the mosquito Anopheles gambiae , 2002 .

[157]  E. van Marck,et al.  Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[158]  Xiao-Fan Wang,et al.  Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite , 2002 .

[159]  J. Ribeiro,et al.  A snake venom phospholipase A(2) blocks malaria parasite development in the mosquito midgut by inhibiting ookinete association with the midgut surface. , 2001, The Journal of experimental biology.

[160]  K Dietz,et al.  Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[161]  R. Sinden,et al.  P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions , 2001, The EMBO journal.

[162]  S. Hoffman,et al.  DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation. , 2001, International journal for parasitology.

[163]  R. Hayward,et al.  Disruption of Plasmodium falciparumChitinase Markedly Impairs Parasite Invasion of Mosquito Midgut , 2001, Infection and Immunity.

[164]  R. Carter.  Transmission blocking malaria vaccines. , 2001, Vaccine.

[165]  S. Yoshida,et al.  Bacteria expressing single-chain immunotoxin inhibit malaria parasite development in mosquitoes. , 2001, Molecular and biochemical parasitology.

[166]  F. Kafatos,et al.  Molecular interactions between Anopheles stephensi midgut cells and Plasmodium berghei: the time bomb theory of ookinete invasion of mosquitoes , 2000, The EMBO journal.

[167]  R. Carter,et al.  Commitment to sexual differentiation in the human malaria parasite, Plasmodium falciparum , 2000, Parasitology.

[168]  Doris Ma Fat,et al.  WHO Library Cataloguing-in-Publication Data , 2001 .

[169]  S. Bennett,et al.  Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infants. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[170]  E. Walker,et al.  Midgut bacteria in Anopheles gambiae and An. funestus (Diptera: Culicidae) from Kenya and Mali. , 1998, Journal of medical entomology.

[171]  C. Beard,et al.  Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[172]  J. Charlwood,et al.  Absence of relationships between selected human factors and natural infectivity of Plasmodium falciparum to mosquitoes in an area of high transmission , 1996, Parasitology.

[173]  P. Barr,et al.  Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum , 1994, Infection and immunity.

[174]  R. Konings,et al.  Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. , 1993, Molecular and biochemical parasitology.

[175]  J. Trape,et al.  Vector density gradients and the epidemiology of urban malaria in Dakar, Senegal. , 1992, The American journal of tropical medicine and hygiene.

[176]  F. Collins,et al.  The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[177]  R. Carter,et al.  Commitment of the malaria parasite Plasmodium falciparum to sexual and asexual development , 1990, Parasitology.

[178]  R. Rosenberg,et al.  An estimation of the number of malaria sporozoites ejected by a feeding mosquito. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[179]  R. Carter,et al.  Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. , 1979, Bulletin of the World Health Organization.

[180]  R. Sinden,et al.  Plasmodium falciparum gametocytes: their longevity and infectivity , 1977, Parasitology.

[181]  K. Rieckmann,et al.  Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. , 1968, Bulletin of the World Health Organization.

[182]  G. Macdonald,et al.  THE MALARIA PARASITE RATE AND INTERRUPTION OF TRANSMISSION. , 1964, Bulletin of the World Health Organization.

[183]  G. Saunders.  The treatment of malaria. , 1947, Missouri medicine.

[184]  Neuroscience of Psychoactive Substance Use and Dependence Summary World Health Organization Geneva Who Library Cataloguing-in-publication Data , 2022 .